Comments on: Photobiomodulation Creates Multi-factorial Pathways

By: Beverly Santo

Beverly Santo — Tue, 11 Feb 2020 22:30:39 +0000

My husband has AD and we have been using the Vie Light for approximately 12 weeks, 6 times a week. At the end of the 12 weeks, we will go to either 3 times a week or every other day depending on what I can learn from any additional research. Can you direct me to any other research that specifically addressed the number of times per week the person used the devices?
I have been keeping a journal throughout the time we’ve been using the devices, and I will share what we’ve learned soon.
Thank you.
Bev. Santo

By: Vielight

Vielight — Thu, 19 Dec 2019 14:31:29 +0000

In reply to Tom.

Hello Tom,
Thank you for your interest and your questions. Please see replies below:
1. There is no difference between the Neuro Gamma and Neuro RX Gamma in terms of the output or any other factor that could affect efficacy of the devices. The differences are only relevant to the special regulatory guidelines for the devices used in a trial, and they are not affecting the performance of the device.
2. The results of the study will show whether the devices provide sufficient efficacy to be considered medical devices. If that will be the case, no changes to these devices will be made.
3. We are always working on something new and will make relevant announcements in due course as appropriate.

By: Vielight

Vielight — Thu, 19 Dec 2019 14:23:53 +0000

In reply to Linda. Hi Linda, Please reach out to us directly, as one of the criteria is the proximity to one of the study sites. We would need to know where you are located, and if there is a study site nearby, then you can be considered as a study subject.

By: Tom

Tom — Sat, 16 Nov 2019 07:38:29 +0000

1. What are the actual differences (e.g. more power, etc.) between the Neuro RX Gamma (used in the clinical trials) vs the Neuro GAMMA and APLHA, and will the non RX versions deliver similar results?

2. Since the results of the trials will be used to improve the efficacy of the Vielight devices, this infers that the current models may be changed over time to deliver better results. If this happens, will Vielight exchange the out of date versions for the newer more effective versions?

3. Are there any current plans to update the current versions in the near future, i.e. a roadmap for these devices?

By: Linda

Linda — Sat, 09 Nov 2019 22:36:40 +0000

May I join the study

By: Robert Sheeler

Robert Sheeler — Fri, 09 Aug 2019 02:59:00 +0000

Hello,
Can you please tell us when this trial is scheduled for completion?